The price of ruxolitinib/ruxolitinib cream is high: how much does a box cost?

Ruxolitinib/ruxolitinib cream (ruxolitinib) As a topical therapeutic drug, ruxolitinib has shown significant efficacy in the treatment of immune-mediated skin diseases in recent years. It is a JAK inhibitor developed by the American company Incyte. It mainly reduces abnormal activation of the immune system by inhibiting the JAK-STAT signaling pathway, thereby alleviating the resulting skin inflammatory response. Ruxolitinib ointment has been approved in the European and American markets and is widely used in the treatment of a variety of skin diseases, especially in the topical treatment of atopic dermatitis (AD), vitiligo and other diseases, showing good therapeutic effects.

The indications for ruxolitinib ointment mainly include atopic dermatitis (eczema), vitiligo and other immune-mediated skin diseases. Atopic dermatitis is a common chronic inflammatory skin disease, usually accompanied by severe itching and redness and swelling of the skin, and patients often require long-term management. Ruxolitinib can effectively relieve these symptoms and reduce skin inflammation by locally inhibiting the JAK-STAT pathway. It has fewer side effects than traditional steroid drugs and is particularly suitable for long-term treatment. Vitiligo is another skin disease caused by immune system disorders. Ruxolitinib ointment can also effectively relieve the symptoms of this disease by reducing the inflammatory response.

However, ruxolitinib ointment has not yet been officially launched in mainland China. If patients need to use the drug, they usually need to purchase it through overseas channels. Ruxolitinib ointment has two original and generic versions abroad, with large price differences. The common specification of the European version is1.5%*60g. The price per box is about 20,000 yuan. The specific price will be affected by exchange rate fluctuations and may fluctuate to a certain extent. For many patients, this price is undoubtedly a considerable burden.

In contrast, imitation versions from countries such as Bangladesh provide a more affordable option. The specifications of generic drugs are usually 1.5%*30g, and each box sells for about more than 600 yuan, which is significantly lower than the original product. Although generic drugs are more affordable, patients still need to pay attention to the source and quality of the drug when choosing to ensure its efficacy and safety.

Reference: https://www.opzelura.com/